To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1356982
Sale price1.055,10 €
|
Letrozole Related Compound A (25 mg) (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile) |
R256A0 | 112809-52-6 | 1.055,10 € | |
|
USP-1357045
Sale price1.055,10 €
|
Leflunomide Related Compound A (100 mg) (4-(trifluoromethyl)aniline) |
R108F0 | 455-14-1 | 1.055,10 € | |
|
USP-1357056
Sale price1.133,39 €
|
Leflunomide Related Compound B (20 mg) (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide |
R12690 | 163451-81-8 | 1.133,39 € | |
|
USP-1357067
Sale price979,16 €
|
Leflunomide Related Compound C (10 mg) (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide) |
R214P0 | 61643-23-0 | 979,16 € | |
|
USP-1357089
Sale price1.203,50 €
|
Teriflunomide Related Compound B (25 mg) (2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide) |
F20030 | 24522-30-3 | 1.203,50 € | |
|
USP-1357090
Sale price361,05 €
|
Conjugated Linoleic Acids - Triglycerides (3 x 100 mg) |
F100V0 | N/A | 361,05 € | |
|
USP-1357125
Sale price1.070,29 €
|
Lacosamide Related Compound B (30 mg) (2-Acetamido-3-(benzylamino)-3-oxopropyl acetate) |
R164Y0 | 1822463-67-1 | 1.070,29 € | |
|
USP-1357147
Sale price1.070,29 €
|
Lacosamide Related Compound D (30 mg) (2-Amino-N-benzyl-3-methoxypropanamide oxalate) |
R162N0 | 1379592-19-4 | 1.070,29 € | |
|
USP-1357158
Sale price996,68 €
|
Lacosamide S-enantiomer (30 mg) ((S)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide) |
R162P0 | 175481-37-5 | 996,68 € | |
|
USP-1357170
Sale price1.070,29 €
|
Lacosamide Related Compound F (30 mg) (2-Acetamido-N-benzyl-3-hydroxypropanamide) |
R175G0 | 171623-02-2 | 1.070,29 € | |
|
USP-1357486
Sale price1.473,41 €
|
Latanoprost Related Compound A (50 mg) (Isopropyl (E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoate) |
R18210 | 913258-34-1 | 1.473,41 € | |
|
USP-1357497
Sale price1.308,66 €
|
Latanoprost Related Compound B (25 mg) (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) |
R028M0 | 145773-22-4 | 1.308,66 € | |
|
USP-1357522
Sale price1.320,34 €
|
Latanoprost Related Compound D (25 mg) (COLD SHIPMENT REQUIRED) |
R13240 | 477884-78-9 | 1.320,34 € | |
|
USP-1357533
Sale price1.374,09 €
|
Latanoprost Related Compound E (25 mg) ((Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid) |
R231N0 | 41639-83-2 | 1.374,09 € | |
|
USP-1357945
Sale price350,53 €
|
Genomic DNA for Lentiviral Integration Copy Number (qPCR) (5 µg) |
F24140 | N/A | 350,53 € | |
|
USP-1358400
Sale price642,64 €
|
[Pro(Ac)]1-Leuprolide (10mg) (5-Oxo-N-acetyl-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide) |
F221N0 | 211108-59-7 | 642,64 € |
